Mr. Taschuk has over twenty five years business experience including corporate strategy development, manufacturing, market development and finance. Prior to Radient, Mr. Taschuk was a partner and CEO of JAG Flocomponents LP.

JAG Flocomponents LP manufactured industrial valves with operations in six countries and customers in over twenty countries.

During his time with JAG Flocomponents, he oversaw the expansion of the Company into international markets.

Mr. Taschuk is also a Director of Tyhee Gold Corp. (TDC: TSX.V) and was previously a Director of the International Diabetes Federation and a Director and Chair of the Board of the Canadian Diabetes Association.

Mr. Taschuk is a Chartered Accountant and holds a Bachelor of Commerce Degree from the University of Alberta.

Dr. Splinter was the founding President of Radient. He is experienced in strategic planning, technical assessment and development of process technologies, business leadership, and engineering project management. Prior to founding Radient, Dr. Splinter served as Director of Chemical & Environmental Processes at BC Research, where he built and managed a team of scientists, engineers and technologists providing contract R&D; services to various clients in the area of chemical and biochemical process development. Dr. Splinter is an expert in interfacial phenomena, having earned a Ph.D. in Engineering Science in 1994. He has authored or co-authored numerous scientific publications and patents and has been invited as a speaker at international science conferences. In 2003, Dr. Splinter was awarded a prestigious 5NR Science Award for Leadership in Sustainable Development for his work in advancing MAP(TM).

Formerly one of Canada's leading portfolio managers when he was at Front Street Capital focusing on technology and growth related investments. Prakash also spent time at Dominion Bond Rating Services, analyzing and rating structured investment products. He holds a Financial Engineering degree from York University, an MBA from the Schulich School of Business, and an undergraduate degree in Chemical Engineering.

Milo Fisher has over 15 years of experience in the biotechnology industry including production of commercial active pharmaceutical ingredients, scale-up, technology transfer and contract manufacturing. He is well versed in scheduling and overseeing all manufacturing operations under full cGMP as well as ensuring that all manufacturing staff are fully trained to operate unit equipment under GMP guidelines. Additionally, he provides solid leadership to materials management and related manufacturing support operations. He held positions with Apotex Fermentation, SYNSORB Biotech Inc. KS Avicenna and QSV Biologics Ltd. Currently, Milo is overseeing the construction and fit-up of the new ingredient manufacturing facility capable of processing 5 tons of material under ISO and GMP.

Tomasz has over 15 years of experience from pharmaceutical and medical devices industry.

His interdisciplinary experience spanning areas of drug design, formulation and analytical development, development and technology transfer of manufacturing processes, cross-functional project management and process risk analysis.

He began his career at Viscoplast S.A. (currently 3M Viscoplast SA) as Specialist in Technology & Development Department, carried out a preclinical drug discovery and development in Canadian Government Laboratories and prior to his position at Radient he held senior scientific position in Supratek Pharma Inc. Tomasz graduated from University of Wroclaw, with PhD in Organic Chemistry.

Mike has over ten years of senior management experience including P&L; responsibility for businesses generating from $40 million to $300 million in annual revenue. Prior to Radient, Mike was Vice President and General Manager in a private equity-backed business which ultimately sold for over $750,000,000, generating a significant return for shareholders. Most recently, Mike was Managing Partner of Foundation Equity, an Edmonton-based venture capital firm. Mike holds a B.Comm from the University of Alberta.

Dave has more than 30 years of engineering and plants operations experience in multiple industries including biotechnology, chemicals, and explosives. He has previously the operations team a multinational company that generated $500 million in sales. In addition Dave has provided his expertise in corporate strategy, product development, business development and operation to companies is various stages of growth both domestically and internationally.

Dave has BSc. in Chemical Engineering.

Marilena Radoiu is a Chartered Chemist (CChem) and a Member of the Royal Society of Chemistry (MRSC). She received a Ph.D. in Technological Organic Chemistry from the Polytechnic University of Bucharest in 1998 and an Executive MBA from the Ecole de Management Lyon (EM Lyon) in 2017.

Dr. Radoiu has extensive work experience in different international academic and industrial environments. She has worked for more than 15 years in various countries (Romania, Canada, UK and France) in the development of microwave-assisted technologies with applications to chemical synthesis, biomass extraction, plasma, food etc. Her work has included engineering and development of novel industrial and scientific standard and custom products, such as Zenith Etch and Sirius6000 (microwave plasma reactors for semiconductor gas cleaning), laboratory equipment such as MiniFlow 200 and Minilabotron 2000.

Dr. Radoiu is a fellow member of several professional associations, including the Association for Microwave Power, Education and Research in Europe (AMPERE).

LinkedIn

Frank is a retired executive from the cosmetic and personal care industry. Frank spent 28 years with the L’Oreal group starting in 1977 and had various roles during that time. He began his L’Oreal career overseeing sales for the Consumer Products Division of L’Oreal Canada. He then worked his way to General Manager of the Division then ultimately to CEO of L’Oreal Canada in 1996.

During his tenure as CEO, he oversaw the acquisition/introduction of a number of new brands and restructured certain manufacturing activities. During his time, L’Oreal Canada became the leader in the Canadian cosmetic industry and was one of the most profitable groups in L’Oreal. In late 2000, Frank accepted the role of President of L’Oreal Brazil with a clear mission to accelerate growth through internal and external activities. During his 4 years in Brazil, L’Oreal Brazil became a high profile subsidiary of the L’Oreal Group due to new brand launches, including La Roche, Vichy and Garnier and expanded manufacturing activities.

Prior to his time with the L’Oreal group, from 1975-1977 Frank was the Chief Financial Officer for Vanier UniverselleLtee., a private Canadian cosmetic company. Prior to his time at Vanier, he was a Corporate Credit officer for the Bank of Nova Scotia. Frank holds a Bachelor of Commerce from the University of Montreal and a MBA from the Bordeaux Ecole de Management. Currently, Frank and his wife own and operate an award winning winery in Italy.

Dimitris is Founder of Into The Wild Concepts agency, based in Zurich, Switzerland, that provides concepts bringing charities and business together including business startups and charity awareness campaigns. He has over twenty years of experience in conceiving, developing and promoting ideas and insights.Through his time in London, New York, Athens and Zurich he has provided his services as a film and TV director for large events for 20 years, 15 years of which were as Broadcast Director for ERT (National Greek Television). His projects include work done for the BBC, Chinese Central Television, IAAF World Championships, UNICEF, Athens 2004 Olympic Games, Eurovision, FIFA, political campaigns, documentaries and corporate videos.

Dimitris holds a Masters Degree in Film Direction from New York University-The Tisch School of the Arts and a BA in Film Direction from the School of Cinematography and Television from Lykourgou Stavrakou.

Jith is a successful entrepreneur and over the past 35 years has operated businesses in numerous countries. As Chairman of Gencor Pacific Limited (“Gencor”), a private life sciences product development company, based in California and Hong Kong, he has been instrumental in its rise to prominence among the nutraceutical companies worldwide. Over the past 10 years he has made strategic investment in technology companies and sits on the board of several companies in the US, Canada, Australia, Israel, South Africa, Hong Kong and India.

Mr. Taschuk has over twenty five years business experience including corporate strategy development, manufacturing, market development and finance. Prior to Radient, Mr. Taschuk was a partner and CEO of JAG Flocomponents LP.

JAG Flocomponents LP manufactured industrial valves with operations in six countries and customers in over twenty countries.

During his time with JAG Flocomponents, he oversaw the expansion of the Company into international markets.

Mr. Taschuk is also a Director of Tyhee Gold Corp. (TDC: TSX.V) and was previously a Director of the International Diabetes Federation and a Director and Chair of the Board of the Canadian Diabetes Association.

Mr. Taschuk is a Chartered Accountant and holds a Bachelor of Commerce Degree from the University of Alberta.

Mike has over ten years of senior management experience including P&L; responsibility for businesses generating from $40 million to $300 million in annual revenue. Prior to Radient, Mike was Vice President and General Manager in a private equity-backed business which ultimately sold for over $750,000,000, generating a significant return for shareholders. Most recently, Mike was Managing Partner of Foundation Equity, an Edmonton-based venture capital firm. Mike holds a B.Comm from the University of Alberta.

Harry has over twenty years' experience in various fields such as engineering, real estate, construction and operations. Harry worked as an engineer in training at JMP Manufacturing in India, and moved to Canada in 1992. He held various positions with Inventronics Ltd. over the couse of 5 years. In April 1997, Harry founded Amnor Ltd., the operations of which include the manufacturing and powder coating of electrical, telecommunications, and electronic enclosures and chassis. Since 2002, his interests have expanded to include real estate acquisition and construction, which are conducted by Amnor Group Inc., structural steel manufacturing, in-house general contracting and excavation. Collectively, the Amnor Group of companies employs 40 people. Harry holds a Bachelor in Engineering from Gulbarga University in India.

Mr. Petzel is the Managing Partner of Eldon Capital, an investment and advisory firm focused on international growth investments and buy-out opportunities. Prior to launching Eldon, he was a Managing Director in the Merchant Banking Division of Goldman Sachs, ultimately responsible for private credit in Germany and Scandinavia. Whilst at Goldman has served on the board of several successful companies including Cognis GmbH, a worldwide supplier of specialty chemicals and nutritional ingredients, up to its sale to BASF for €3.1bn in 2010. Mr. Petzel commenced his career as a consultant to the technology sector for McKinsey & Company working in the United States, Europe and Asia. He holds an MBA from Harvard Business School and a Master of Engineering from the Swiss Federal Institute of Technology and was a Visiting Scholar at the Massachusetts Institute of Technology.

Terry Booth is the Founder and CEO of Aurora Cannabis (TSXV-ACB), a producer of medical cannabis and cannabis oils under license from Health Canada. Based in Mountain View County, Alberta, with a 55,200 square foot purpose-built production facility, Aurora is one of the largest and fastest-growing Licensed Producers in Canada. The company has begun construction on “Aurora Sky”, a new highly advanced and automated 800,000 square foot production facility located at Edmonton International Airport. Aurora trades on the TSX Venture Exchange under the symbol “ACB”, and has a recent market capitalization exceeding $900 million.

Terry founded Aurora in 2013 when the Canadian federal government created a new regulatory regime for the establishment of a national medical cannabis system. Investing $2.5 million of his own capital in start-up funding, he secured a 160 acre parcel of land in the foothills of the Rocky Mountains, and designed and built what is now widely recognized as one of the most advanced and efficient cannabis production facilities in the world. Terry has assembled a diverse and highly skilled team of experts from a broad range of disciplines to execute on the company’s business strategy and vision to build the world’s foremost cannabis company.

An entrepreneur and Alberta business leader, Terry has served as President/CEO of six other highly successful businesses, one of which, Superior Safety Codes Inc, has received an award as one of Canada’s top 50 fastest-growing companies.

Terry is a strong supporter of many charitable organizations dedicated to ending family violence and violence against women, including the “Walk a Mile in Her Shoes” campaign. He also regularly participates in reading programs for first grade students.

Terry has four children and two grandchildren, and lives in Edmonton with his wife and youngest son. He coaches youth soccer and enjoys golfing and running.

Dr. Splinter was the founding President of Radient. He is experienced in strategic planning, technical assessment and development of process technologies, business leadership, and engineering project management. Prior to founding Radient, Dr. Splinter served as Director of Chemical & Environmental Processes at BC Research, where he built and managed a team of scientists, engineers and technologists providing contract R&D; services to various clients in the area of chemical and biochemical process development. Dr. Splinter is an expert in interfacial phenomena, having earned a Ph.D. in Engineering Science in 1994. He has authored or co-authored numerous scientific publications and patents and has been invited as a speaker at international science conferences. In 2003, Dr. Splinter was awarded a prestigious 5NR Science Award for Leadership in Sustainable Development for his work in advancing MAP(TM).